These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33674037)

  • 1. Corrigendum to "Flaccidoside II ameliorates collagen-induced arthritis in mice" [Eur. J. Pharmacol. 880 (2020) 173155].
    Zhang GB; Jia ZJ; Zhang MH; Li YJ; Tian LY; Cheng J
    Eur J Pharmacol; 2021 Apr; 897():173963. PubMed ID: 33674037
    [No Abstract]   [Full Text] [Related]  

  • 2. Corrigendum to "Activation of angiotensin II type 2 receptor attenuates lung injury of collagen-induced arthritis by alleviating endothelial cell injury and promoting Ly6C
    Xu Q; Chen J; Ye W; Zhang C; Wang D; Wei W; Hu S
    Eur J Pharmacol; 2023 Sep; 954():175907. PubMed ID: 37460388
    [No Abstract]   [Full Text] [Related]  

  • 3. Corrigendum to "Exenatide ameliorates hydrogen peroxide-induced pancreatic β-cell apoptosis through regulation of METTL3-mediated m
    Zhou S; Sun Y; Xing Y; Wang Z; Wan S; Yao X; Hua Q; Meng X; Cheng J; Zhong M; Lv K; Kong X
    Eur J Pharmacol; 2023 May; 946():175652. PubMed ID: 36924576
    [No Abstract]   [Full Text] [Related]  

  • 4. Hypouricemic effect of flaccidoside II in rodents.
    Zhang GB; Ren SS; Wang BY; Tian LQ; Bing FH
    J Nat Med; 2017 Jan; 71(1):329-333. PubMed ID: 27771848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corrigendum to "Essential role of Ca
    Tsubota M; Matsui K; Nakano M; Kajitani R; Ishii Y; Tomochika K; Nishikawa Y; Fukushi S; Yamagata A; Sekiguchi F; Okada T; Toyooka N; Kawabata A
    Eur J Pharmacol; 2021 Feb; 892():173795. PubMed ID: 33358247
    [No Abstract]   [Full Text] [Related]  

  • 6. Corrigendum to "Protective effects of cortex fraxini coumarines against oxonate-induced hyperuricemia and renal dysfunction in mice" [Eur. J. Pharmacol. 666 (2011) 196-204].
    Li JM; Zhang X; Wang X; Xie YC; Kong LD
    Eur J Pharmacol; 2022 Feb; 916():174740. PubMed ID: 34996605
    [No Abstract]   [Full Text] [Related]  

  • 7. Corrigendum to "Tumor suppression effects of myoepithelial cells on mice breast cancer" [Eur. J. Pharmacol. 765 (2015) 171-178].
    Farhangi B; Latifpour M; Alizadeh AM; Khodayari H; Khodayari S; Khaniki M; Ghasempour S
    Eur J Pharmacol; 2016 Jul; 782():119. PubMed ID: 27180042
    [No Abstract]   [Full Text] [Related]  

  • 8. Corrigendum to "The effect of cinnamaldehyde on passive avoidance memory and hippocampal Akt, ERK and GSK-3β in mice" [Eur. J. Pharmacol. 859 (2019) 172530].
    SoukhakLari R; Borhani-Haghighi A; Farsadrooh A; Moezi L; Pirsalami F; Kazerouni A; Safari A; Moosavi M
    Eur J Pharmacol; 2020 Apr; 873():173013. PubMed ID: 32087858
    [No Abstract]   [Full Text] [Related]  

  • 9. Corrigendum to: "Preventive and therapeutic effects of caffeic acid against inflammatory injury in striatum of MPTP-treated mice": [Eur.J.Pharmacol.670(2011)441-447].
    Tsai SJ; Chao CY; Yin MC
    Eur J Pharmacol; 2018 Jan; 819():293. PubMed ID: 29325911
    [No Abstract]   [Full Text] [Related]  

  • 10. Corrigendum to "Sulfur dioxide derivatives attenuates consolidation of contextual fear memory in mice" [Eur. J. Pharmacol. 914 2021 174658].
    Wang X; Zhao Y; Shi X; Gong M; Hao Y; Fu Y; Velez de-la-Paz OI; Wang X; Du Y; Guo X; Song L; Meng L; Gao Y; Yin X; Wang S; Shi H; Shi Y
    Eur J Pharmacol; 2022 Mar; 918():174794. PubMed ID: 35125204
    [No Abstract]   [Full Text] [Related]  

  • 11. Corrigendum to "Pretreatment with obestatin reduces the severity of ischemia/reperfusion-induced acute pancreatitis in rats" [Eur. J. Pharmacol. 760 (2015) 113-121].
    Bukowczan J; Warzecha Z; Ceranowicz P; Kuśnierz-Cabala B; Tomaszewska R; Dembinski A
    Eur J Pharmacol; 2019 Jan; 842():384-385. PubMed ID: 30554633
    [No Abstract]   [Full Text] [Related]  

  • 12. Corrigendum to "P2Y14 receptor in trigeminal ganglion contributes to neuropathic pain in mice" [Eur. J. Pharmacol. 931 (2022) 175211].
    Lin J; Fang X; Liu F; Zhang Y; Li Y; Fang Z; Tang Q; Li C; Zhou C; Shen J
    Eur J Pharmacol; 2022 Oct; 932():175266. PubMed ID: 36096845
    [No Abstract]   [Full Text] [Related]  

  • 13. Corrigendum to "Low-intensity pulsed ultrasound prevents angiotensin II-induced aortic smooth muscle cell phenotypic switch via hampering miR-17-5p and enhancing PPAR-γ" [Eur. J. Pharmacol. 911 (2021):174509].
    Zhao K; Wu T; Yang C; Pan H; Xu T; Zhang J; Guo X; Tu J; Zhang D; Kong X; Zhou B; Sun W
    Eur J Pharmacol; 2024 Jul; 975():176662. PubMed ID: 38795429
    [No Abstract]   [Full Text] [Related]  

  • 14. Corrigendum to "Vitexin protects against ethanol-induced liver injury through Sirt1/p53 signaling pathway" [Eur. J. Pharmacol. 873 (2020) 173007].
    Yuan H; Duan S; Guan T; Yuan X; Lin J; Hou S; Lai X; Huang S; Du X; Chen S
    Eur J Pharmacol; 2020 Aug; 880():173160. PubMed ID: 32460965
    [No Abstract]   [Full Text] [Related]  

  • 15. Corrigendum to 'Dezocine attenuates the remifentanil-induced postoperative hyperalgesia by inhibition of phosphorylation of CaMKⅡα' [Eur J Pharmacol. 2020 Feb 15; 869: 172882].
    Zhou J; Qi F; Hu Z; Zhang L; Li Z; Wang ZJ; Tang H; Chen Z
    Eur J Pharmacol; 2021 Oct; 908():174359. PubMed ID: 34298417
    [No Abstract]   [Full Text] [Related]  

  • 16. Corrigendum to "Cannabinoid receptors are involved in the protective effect of a novel curcumin derivative C66 against CCl4-induced liver fibrosis" [Eur. J. Pharmacol. 779 (2016) 20-30 doi: 10.1016/j.ejphar.2016.02.067].
    Huang SS; Chen DZ; Wu H; Chen RC; Du SJ; Dong JJ; Liang G; Xu LM; Wang XD; Yang YP; Yu ZP; Feng WK; Chen YP
    Eur J Pharmacol; 2024 Aug; 977():176713. PubMed ID: 38849042
    [No Abstract]   [Full Text] [Related]  

  • 17. Corrigendum to 'Reduced nitric oxide-mediated relaxation and endothelial nitric oxide synthase expression in the tail arteries of streptozotocin-induced diabetic rats' [Eur. J. Pharmacol. 773 (2016) 78-84].
    Mokhtar SS; Vanhoutte PM; Leung SWS; Suppian R; Yusof MI; Rasool AHG
    Eur J Pharmacol; 2017 Oct; 812():264. PubMed ID: 28915977
    [No Abstract]   [Full Text] [Related]  

  • 18. Corrigendum to "Tenuigenin exhibits protective effects against LPS-induced acute kidney injury via inhibiting TLR4/NF-κB signaling pathway" [Eur. J. Pharmacol. 791 (2016) 229-234].
    Haiyan F; Zhansheng H; Xingwei D; Qiuhong Z; Rongbin Z; Hongyang D
    Eur J Pharmacol; 2016 Dec; 792():78. PubMed ID: 27916228
    [No Abstract]   [Full Text] [Related]  

  • 19. Corrigendum to "α-Conidendrin inhibits the expression of intercellular adhesion molecule-1 induced by tumor necrosis factor-α in human adenocarcinoma A549 cells" [Eur. J. Pharmacol. 890 (2021) 173651].
    Vo NT; Sasaki S; Miyake Y; Nguyen NT; Dang PH; Thi Nguyen MT; Kataoka T
    Eur J Pharmacol; 2021 Oct; 909():174453. PubMed ID: 34462123
    [No Abstract]   [Full Text] [Related]  

  • 20. Corrigendum to "N-arachidonoylphenolamine alleviates ischaemia/reperfusion-induced cardiomyocyte necroptosis by restoring proteasomal activity" [Eur. J. Pharmacol. (2024) 963 176235].
    Bai JQ; Li PB; Li CM; Li HH
    Eur J Pharmacol; 2024 Feb; 965():176316. PubMed ID: 38216371
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.